Français

For Universal Life Investment Accounts

CI Global Health Sciences Corporate Class A

Sector Equity

As Of: Mar 31, 2021

Fund Objective

This fund's objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio advisor believes would benefit from developments in the health sciences industry.

Asset Allocation

Asset Percent
US Equity 66.01%
International Equity 28.97%
Cash and Equivalents 3.10%
Canadian Equity 1.92%

Sector Allocation

Sector Percent
Healthcare 83.38%
Consumer Services 7.46%
Cash and Cash Equivalent 3.10%
Financial Services 3.09%
Real Estate 1.69%
Other 1.28%

Geo Allocation

Region Percent
North America 71.03%
Europe 15.65%
Asia 12.19%
Latin America 1.13%

Top Holdings

Name Percent
Alexion Pharmaceuticals Inc 6.75%
SeaSpine Holdings Corp 6.06%
Bristol-Myers Squibb Co 5.37%
CVS Health Corp 5.22%
Takeda Pharmaceutical Co Ltd 4.78%
Ionis Pharmaceuticals Inc 4.14%
Biogen Idec Inc 4.06%
Fresenius Medical Care AG & Co KGaA 3.71%
Gilead Sciences Inc 3.67%
Astellas Pharma Inc 3.20%

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.33%
Total Assets
(in millions)
$199.39

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Investments Inc

Investment Style

This investment's style box characteristics are Large Blend.

Fund Growth

Period

Growth Summary

Table below lists the current growth and return for an investment of $10,000 at the fund's inception:

Investment Value $79,284.17
Rate of Return +692.84%
Values over period specified.

Legend

CI Global Health Sciences Corporate Class A

S&P/TSX Composite Index TR


Performance

1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr Inception
Fund 3.9 5.0 15.8 5.0 32.1 8.8 6.7 12.4 8.7
S&P/TSX Composite Index TR 3.9 8.1 17.7 8.1 44.2 10.2 10.1 6.0 -
Quartile 1 2 2 2 3 4 4 4 -

Calendar Performance

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Fund 11.2 12.0 1.1 6.4 -19.1 14.1 19.6 61.8 30.4 0.8
S&P/TSX Composite Index TR 5.6 22.9 -8.9 9.1 21.1 -8.3 10.6 13.0 7.2 -8.7
Quartile 3 4 3 4 4 3 3 1 1 2

Volatility

Volatility: 8

Risk vs. Return

Period

CI Global Health Sciences Corporate Class A

Median

Other - Sector Equity

Risk & Tax Efficiency

3 Yr 5 Yr 10 Yr
Standard Deviation 17.99 16.60 16.46
Beta 0.75 0.73 0.64
Alpha 0.02 0.00 0.09
R-Squared 0.50 0.36 0.21
Sharpe Ratio 0.50 0.42 0.74
Sortino Ratio 0.52 0.35 0.86
Treynor 0.12 0.09 0.19
Tax Efficiency 87.52 87.95 91.18

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.33%
Total Assets
(in millions)
$199.39

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Investments Inc

Investment Style

This investment's style box characteristics are Large Blend.